Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells
出版年份 2021 全文链接
标题
Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells
作者
关键词
-
出版物
Blood Advances
Volume 5, Issue 5, Pages 1137-1153
出版商
American Society of Hematology
发表日期
2021-02-27
DOI
10.1182/bloodadvances.2020001996
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tandem Paired Nicking Promotes Precise Genome Editing with Scarce Interference by p53
- (2020) Toshinori Hyodo et al. Cell Reports
- Partner independent fusion gene detection by multiplexed CRISPR-Cas9 enrichment and long read nanopore sequencing
- (2020) Christina Stangl et al. Nature Communications
- Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
- (2020) Giulia Pavani et al. Nature Communications
- Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia
- (2019) Sarah Marktel et al. NATURE MEDICINE
- CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
- (2019) Grégoire Cullot et al. Nature Communications
- Highly efficient therapeutic gene editing of human hematopoietic stem cells
- (2019) Yuxuan Wu et al. NATURE MEDICINE
- Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
- (2019) Christopher E. Nelson et al. NATURE MEDICINE
- CRISPResso2 provides accurate and rapid genome editing sequence analysis
- (2019) Kendell Clement et al. NATURE BIOTECHNOLOGY
- Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response
- (2019) Giulia Schiroli et al. Cell Stem Cell
- Introducing a Spectrum of Long-Range Genomic Deletions in Human Embryonic Stem Cells Using Type I CRISPR-Cas
- (2019) Adam E. Dolan et al. MOLECULAR CELL
- Editing the Sickle Cell Disease Mutation in Primary Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates
- (2019) Zulema Romero et al. MOLECULAR THERAPY
- Alpha Globin Gene Mutation: A Major Determinant of Hydroxyurea Response in Transfusion-Dependent HbE-β-Thalassaemia
- (2019) Sujana Biswas et al. ACTA HAEMATOLOGICA
- Development of hRad51–Cas9 nickase fusions that mediate HDR without double-stranded breaks
- (2019) Holly A. Rees et al. Nature Communications
- Gene correction for SCID-X1 in long-term hematopoietic stem cells
- (2019) Mara Pavel-Dinu et al. Nature Communications
- High levels of AAV vector integration into CRISPR-induced DNA breaks
- (2019) Killian S. Hanlon et al. Nature Communications
- Synergistic silencing of α-globin and induction of γ-globin by histone deacetylase inhibitor, vorinostat as a potential therapy for β-thalassaemia
- (2019) Sachith Mettananda et al. Scientific Reports
- Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency
- (2019) David N. Nguyen et al. NATURE BIOTECHNOLOGY
- Expanding the editable genome and CRISPR–Cas9 versatility using DNA cutting-free gene targeting based on in trans paired nicking
- (2019) Xiaoyu Chen et al. NUCLEIC ACIDS RESEARCH
- Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus
- (2018) Chiara Antoniani et al. BLOOD
- Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing
- (2018) Chang Li et al. BLOOD
- Variability of homozygous sickle cell disease: The role of alpha and beta globin chain variation and other factors
- (2018) Graham R. Serjeant et al. BLOOD CELLS MOLECULES AND DISEASES
- Molecular Basis and Genetic Modifiers of Thalassemia
- (2018) Sachith Mettananda et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements
- (2018) Michael Kosicki et al. NATURE BIOTECHNOLOGY
- Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding
- (2018) Gabriella E. Martyn et al. NATURE GENETICS
- Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
- (2018) Alexis A. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Common α-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and disease
- (2018) Laura M. Raffield et al. PLoS Genetics
- Large deletions induced by Cas9 cleavage
- (2018) Fatwa Adikusuma et al. NATURE
- An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype
- (2018) Leslie Weber et al. Molecular Therapy-Methods & Clinical Development
- Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements
- (2018) Annalisa Lattanzi et al. MOLECULAR THERAPY
- Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing
- (2017) Jianguo Wen et al. Journal of Hematology & Oncology
- Management of iron overload in hemoglobinopathies
- (2017) S. Allali et al. TRANSFUSION CLINIQUE ET BIOLOGIQUE
- Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
- (2017) Sachith Mettananda et al. Nature Communications
- In trans paired nicking triggers seamless genome editing without double-stranded DNA cutting
- (2017) Xiaoyu Chen et al. Nature Communications
- Next-generation mapping: a novel approach for detection of pathogenic structural variants with a potential utility in clinical diagnosis
- (2017) Hayk Barseghyan et al. Genome Medicine
- On Modeling Human Leukocyte Antigen–Identical Sibling Match Probability for Allogeneic Hematopoietic Cell Transplantation: Estimating the Need for an Unrelated Donor Source
- (2016) Kelsey Besse et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Selective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia
- (2016) Sachith Mettananda et al. HAEMATOLOGICA
- Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone
- (2016) Maria Rosa Lidonnici et al. HAEMATOLOGICA
- Open-source guideseq software for analysis of GUIDE-seq data
- (2016) Shengdar Q Tsai et al. NATURE BIOTECHNOLOGY
- A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition
- (2016) Elizabeth A Traxler et al. NATURE MEDICINE
- Selective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia
- (2016) Sachith Mettananda et al. HAEMATOLOGICA
- Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone
- (2016) Maria Rosa Lidonnici et al. HAEMATOLOGICA
- -Globin as a molecular target in the treatment of -thalassemia
- (2015) S. Mettananda et al. BLOOD
- Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
- (2015) Jianbin Wang et al. NATURE BIOTECHNOLOGY
- Efficient inversions and duplications of mammalian regulatory DNA elements and gene clusters by CRISPR/Cas9
- (2015) Jinhuan Li et al. Journal of Molecular Cell Biology
- Homology-directed repair in rodent zygotes using Cas9 and TALEN engineered proteins
- (2015) Séverine Ménoret et al. Scientific Reports
- Biosafety Challenges for Use of Lentiviral Vectors in Gene Therapy
- (2014) Michael Rothe et al. CURRENT GENE THERAPY
- Gene Therapy for Hemoglobinopathies
- (2014) Shanmuganathan Chandrakasan et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- The Correlation of α-Globin Gene Mutations and theXmnI Polymorphism with Clinical Severity of Hb E/β-Thalassemia
- (2014) Pimlak Charoenkwan et al. HEMOGLOBIN
- Targeted genome editing in human repopulating haematopoietic stem cells
- (2014) Pietro Genovese et al. NATURE
- GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
- (2014) Shengdar Q Tsai et al. NATURE BIOTECHNOLOGY
- Easy quantitative assessment of genome editing by sequence trace decomposition
- (2014) Eva K. Brinkman et al. NUCLEIC ACIDS RESEARCH
- The Co-Inheritance of Alpha-Thalassemia and Sickle Cell Anemia Is Associated with Better Hematological Indices and Lower Consultations Rate in Cameroonian Patients and Could Improve Their Survival
- (2014) Maryam Bibi Rumaney et al. PLoS One
- Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
- (2013) F. Ann Ran et al. CELL
- PARP-mediated repair, homologous recombination, and back-up non-homologous end joining-like repair of single-strand nicks
- (2013) Michael J. Metzger et al. DNA REPAIR
- A Double-Switch Vector System Positively Regulates Transgene Expression by Endogenous microRNA Expression (miR-ON Vector)
- (2013) Mario Amendola et al. MOLECULAR THERAPY
- Establishment of Immortalized Human Erythroid Progenitor Cell Lines Able to Produce Enucleated Red Blood Cells
- (2013) Ryo Kurita et al. PLoS One
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- The Hemoglobin E Thalassemias
- (2013) S. Fucharoen et al. Cold Spring Harbor Perspectives in Medicine
- The Molecular Basis of -Thalassemia
- (2013) S. L. Thein Cold Spring Harbor Perspectives in Medicine
- Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia
- (2012) W. Saber et al. BLOOD
- The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia
- (2012) Swee Lay Thein BLOOD REVIEWS
- Macrophages prevent human red blood cell reconstitution in immunodeficient mice
- (2011) Z. Hu et al. BLOOD
- The challenge of haemoglobinopathies in resource-poor countries
- (2011) David J. Weatherall BRITISH JOURNAL OF HAEMATOLOGY
- Comparative analysis of FV vectors with human α- or β-globin gene regulatory elements for the correction of β-thalassemia
- (2011) I Morianos et al. GENE THERAPY
- Lethal toxicity caused by expression of shRNA in the mouse striatum: implications for therapeutic design
- (2011) J N Martin et al. GENE THERAPY
- Variants in genetic modifiers of -thalassemia can help to predict the major or intermedia type of the disease
- (2011) C. Badens et al. HAEMATOLOGICA
- The New Self-Inactivating Lentiviral Vector for Thalassemia Gene Therapy Combining Two HPFH Activating Elements Corrects Human Thalassemic Hematopoietic Stem Cells
- (2011) Eleni Papanikolaou et al. HUMAN GENE THERAPY
- Correction of β654-thalassaemia mice using direct intravenous injection of siRNA and antisense RNA vectors
- (2011) Shu-Yang Xie et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Production, Purification and Characterization of Adeno-Associated Vectors
- (2010) Eduard Ayuso et al. CURRENT GENE THERAPY
- Beta-thalassemia
- (2010) Antonio Cao et al. GENETICS IN MEDICINE
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
- (2010) Marina Cavazzana-Calvo et al. NATURE
- Single-strand nicks induce homologous recombination with less toxicity than double-strand breaks using an AAV vector template
- (2010) Michael J. Metzger et al. NUCLEIC ACIDS RESEARCH
- α-thalassaemia
- (2010) Cornelis L Harteveld et al. Orphanet Journal of Rare Diseases
- Lentiviral delivery of short hairpin RNAs
- (2009) N. Manjunath et al. ADVANCED DRUG DELIVERY REVIEWS
- Effect of α-gene numbers on phenotype of HbE/β thalassemia patients
- (2009) Vineeta Sharma et al. ANNALS OF HEMATOLOGY
- siRNA-mediated reduction of -globin results in phenotypic improvements in -thalassemic cells
- (2008) H. P. J. Voon et al. HAEMATOLOGICA
- Single-strand break repair and genetic disease
- (2008) Keith W. Caldecott NATURE REVIEWS GENETICS
- In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of -thalassemia
- (2008) A. Miccio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now